Intratumoral Administration of High-Concentration Nitric Oxide and Anti-mPD-1 Treatment Improves Tumor Regression Rates and Survival in CT26 Tumor-Bearing Mice.
Hila ConfinoYogev SelaYana EpshteinLidor MalkaMatan GoldshteinSelena ChaissonSteve LisiAmir AvnielJedidiah Mercer MonsonFrederick M DirbasPublished in: Cells (2023)
Combining high-concentration NO and immune checkpoint inhibitors warrants further assessment especially in tumors resistant to checkpoint inhibitor therapy.